ValiRx (LON:VAL) Posts Earnings Results

ValiRx (LON:VALGet Free Report) announced its earnings results on Monday. The company reported GBX (0.54) earnings per share for the quarter, Digital Look Earnings reports. The business had revenue of GBX 3 million for the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.

ValiRx Stock Performance

LON:VAL opened at GBX 0.18 on Tuesday. ValiRx has a 52 week low of GBX 0.16 and a 52 week high of GBX 0.85. The company has a fifty day simple moving average of GBX 0.23 and a two-hundred day simple moving average of GBX 0.30. The company has a quick ratio of 1.27, a current ratio of 9.66 and a debt-to-equity ratio of 0.19. The company has a market cap of £1.31 million, a price-to-earnings ratio of -0.19 and a beta of 0.59.

ValiRx Company Profile

(Get Free Report)

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Recommended Stories

Earnings History for ValiRx (LON:VAL)

Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.